Critique Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Sign: Together with chemotherapy, for your treatment method of Grownup individuals with regionally recurrent unresectable or metastatic triple-negative breast cancer who definitely have not acquired prior chemotherapy for metastatic sickness and whose tumours express programmed